wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39204706-B681732F-6F51-4540-8B2C-89B1630FD5E8
Q39204706-B681732F-6F51-4540-8B2C-89B1630FD5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39204706-B681732F-6F51-4540-8B2C-89B1630FD5E8
Lessons learned from adult clinical experience to inform evaluations of VEGF pathway inhibitors in children with cancer.
P2860
Q39204706-B681732F-6F51-4540-8B2C-89B1630FD5E8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39204706-B681732F-6F51-4540-8B2C-89B1630FD5E8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6fbd1f39e9c0d88257d199e2b69f1768d5c74ed6
P2860
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.